R. Janet Whitmore - 24 Dec 2025 Form 4 Insider Report for SOLESENCE, INC. (SLSN)

Role
Director
Signature
/s/ Laura Riffner, Under UPA for R. Janet Whitmore
Issuer symbol
SLSN
Transactions as of
24 Dec 2025
Net transactions value
+$4,787
Form type
4
Filing time
30 Dec 2025, 09:29:40 UTC
Previous filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WHITMORE R JANET Director 1319 MARQUETTE DRIVE, ROMEOVILLE /s/ Laura Riffner, Under UPA for R. Janet Whitmore 30 Dec 2025 0001173970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLSN Common Stock Purchase $2,865 +1,500 +0.07% $1.91 2,085,698 24 Dec 2025 Direct
transaction SLSN Common Stock Purchase $1,922 +1,000 +0.05% $1.92 2,086,698 24 Dec 2025 Direct
holding SLSN Common Stock 2,084,198 24 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLSN Deferred Common Stock 20,030 24 Dec 2025 Common Stock 20,030 Direct F1, F2, F3
holding SLSN Common Stock (right to purchase) 2,000 24 Dec 2025 Common Stock 2,000 $1.85 Direct F4
holding SLSN Common Stock (right to purchase) 20,000 24 Dec 2025 Common Stock 20,000 $4.17 Direct F5
holding SLSN Common Stock (right to purchase) 13,334 24 Dec 2025 Common Stock 13,334 $1.16 Direct F5
holding SLSN Common Stock (right to purchase) 12,600 24 Dec 2025 Common Stock 12,600 $0.6100 Direct F5
holding SLSN Common Stock (Right to Buy) 12,000 24 Dec 2025 Common Stock 12,000 $2.44 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of deferred common stock represents the right to receive one share of common stock.
F2 The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F3 Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
F4 The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85.
F5 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.